Guggenheim Upgrades Cardinal Health (CAH) to Buy

Guggenheim analyst Glen Santangelo upgraded Cardinal Health (NYSE: CAH) from Neutral to Buy with a price target of $52.00 (from $50.00).

• Says stabilizing fundamentals and low expectations offers a skewed risk/reward.

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $43.48 yesterday.

You May Also Be Interested In

• JPMorgan Upgrades TIC Solutions (TIC) to Neutral
• Deutsche Bank Downgrades Straumann Holding AG (STMN:SW) (SAUHF) to Hold
• Kepler Cheuvreux Downgrades Avantium N.V (AVTX:NA) to Reduce